Single User License
INR 19350
Site License
INR 38700
Corporate User License
INR 58050

Service Tax Additional

select a format
Price

Single User License
USD 300
Site License
USD 600
Corporate User License
USD 900

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Oasmia Pharmaceutical AB (OASM)-Financial and Strategic SWOT Analysis Review

Oasmia Pharmaceutical AB (OASM)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH82483FSA
  • |
  • Pages: 25
  • |
  • May 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Oasmia Pharmaceutical AB (Oasmia Pharmaceutical) is a pharmaceutical company that develops drugs for human and veterinary oncology. The company's animal health products include doxophos vet and paccal vet. Its human health products include doxophos, paclical, docecal and OAS-19. Oasmia Pharmaceutical's paclical is a water-soluble formulation of paclitaxel and XR-17 used as anti-cancer substances for treatment of cancers such as breast cancer, lung cancer and ovarian cancer. The company develops products based on in-house research within nanotechnology and company patents. It provides services such as organic synthesis, filling, analysis and freeze-drying, labeling and packaging. The company operates through research facility in Sweden. Oasmia Pharmaceutical is headquartered in Uppsala, Sweden.

Oasmia Pharmaceutical AB Key Recent Developments

Dec 02,2016: Oasmia Pharmaceutical: Interim report for the period May-October 2016

Aug 31,2016: Oasmia Pharmaceutical Appoints Fredrik Gynnerstedt as Chief Financial Officer

Apr 05,2016: Oasmia Pharmaceutical Reports Positive Clinical Study Results for Proprietary XR17 Nanotechnology

Feb 02,2016: Oasmia Pharmaceutical Makes Key Hires; Strengthens Organizational Structure Entering Commercial Phase

This comprehensive SWOT profile of Oasmia Pharmaceutical AB provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Oasmia Pharmaceutical AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Section 1-About the Company

Oasmia Pharmaceutical AB-Key Information

Oasmia Pharmaceutical AB-Overview

Oasmia Pharmaceutical AB-Key Employees

Oasmia Pharmaceutical AB-Key Employee Biographies

Oasmia Pharmaceutical AB-Key Operational Heads

Oasmia Pharmaceutical AB-Major Products and Services

Oasmia Pharmaceutical AB-History

Oasmia Pharmaceutical AB-Company Statement

Oasmia Pharmaceutical AB-Locations And Subsidiaries

Oasmia Pharmaceutical AB-Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Oasmia Pharmaceutical AB-Business Description

Oasmia Pharmaceutical AB-Corporate Strategy

Oasmia Pharmaceutical AB-SWOT Analysis

SWOT Analysis-Overview

Oasmia Pharmaceutical AB-Strengths

Oasmia Pharmaceutical AB-Weaknesses

Oasmia Pharmaceutical AB-Opportunities

Oasmia Pharmaceutical AB-Threats

Oasmia Pharmaceutical AB-Key Competitors

Section 3-Company Financial Performance Charts

Oasmia Pharmaceutical AB-Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Appendix

Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Figures

Oasmia Pharmaceutical AB, Performance Chart

Oasmia Pharmaceutical AB, Ratio Charts

List of Tables

Oasmia Pharmaceutical AB, Key Information

Oasmia Pharmaceutical AB, Key Ratios

Oasmia Pharmaceutical AB, Share Data

Oasmia Pharmaceutical AB, Major Products and Services

Oasmia Pharmaceutical AB, History

Oasmia Pharmaceutical AB, Key Employees

Oasmia Pharmaceutical AB, Key Employee Biographies

Oasmia Pharmaceutical AB, Key Operational Heads

Oasmia Pharmaceutical AB, Other Locations

Oasmia Pharmaceutical AB, Subsidiaries

Oasmia Pharmaceutical AB, Key Manufacturing facilities

Oasmia Pharmaceutical AB, Key Competitors

Oasmia Pharmaceutical AB, SWOT Analysis

Oasmia Pharmaceutical AB, Ratios based on current share price

Oasmia Pharmaceutical AB, Annual Ratios

Oasmia Pharmaceutical AB, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Oasmia Pharmaceutical AB, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com